LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) — all Canadian products
8 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02564874 | APO-LEVOMILNACIPRAN | APOTEX INC | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MG | Approved | |
| 02564831 | APO-LEVOMILNACIPRAN | APOTEX INC | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MG | Approved | |
| 02564858 | APO-LEVOMILNACIPRAN | APOTEX INC | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MG | Approved | |
| 02564866 | APO-LEVOMILNACIPRAN | APOTEX INC | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MG | Approved | |
| 02440970 | FETZIMA | ABBVIE CORPORATION | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MG | Marketed | |
| 02440989 | FETZIMA | ABBVIE CORPORATION | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MG | Marketed | |
| 02440997 | FETZIMA | ABBVIE CORPORATION | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MG | Marketed | |
| 02441004 | FETZIMA | ABBVIE CORPORATION | Capsule (Extended-Release) | Oral | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MG | Marketed |
Browse other molecules: